Health ❯ Healthcare ❯ Diseases

Blood Disorders

Immune Thrombocytopenia Thalassemia Polycythemia Vera Blood Cancers Haemophilia Sickle Cell Disease Leukemia Myelofibrosis

Fulcrum Halts Pociredir Program After FDA Says PRC2 Inhibitors Carry Cancer Risk

FDA meeting minutes concluding a class-level malignancy signal removed a viable path for the EED-targeting sickle cell therapy.

Karnataka Launches Kusuma Sanjeevini to Offer Free Monthly Hemophilia Treatment

FDA Grants Orphan Drug Status to Cellenkos’ CK0804 for Myelofibrosis

FDA Approves Aqvesme for Thalassemia Anemia, First U.S. Therapy for Both Patient Groups

CHMP Recommends Approval of Wayrilz for Refractory ITP in Adults

CHMP Backs Brinsupri as First EU Therapy for Non‑Cystic Fibrosis Bronchiectasis

Indiana University Develops Breakthrough Technique for Bone Marrow Imaging